Dirk Reitsma, M.D.
Dirk Reitsma, M.D., is vice president and head of oncology global product development at PPD. He established and leads the company’s biosimilar services development group, which brings together cross functional, global expertise and resources in the development of biologic drugs.
Dr. Reitsma has extensive clinical development experience, having joined PPD from MedImmune, where he served as vice president of clinical development since 2004. At MedImmune, he led the company’s active clinical oncology programs in biologics and oversaw the expansion of its oncology clinical development department.
Dr. Reitsma’s experience also includes serving as vice president of clinical affairs and medical director at Antigenics, and as associate director and senior clinical research physician in oncology at Novartis Pharmaceuticals. Earlier in his career, he was associate director, clinical research head, clinical section, at Bionetics Research, Inc. and medical advisor in the medical research department at Organon International, Inc. in Rotterdam, The Netherlands.
Dr. Reitsma received a bachelor’s degree in science from the Medical Faculty of Rotterdam and a medical degree from Erasmus University in The Netherlands.